Profiles

Keywords
Last Name
Institution

Connection

John Somberg to Drug Approval

This is a "connection" page, showing publications John Somberg has written about Drug Approval.

 
Connection Strength
 
 
 
6.548
 
  1. Somberg JC. Conflating the approval process and clinical research with pharmacoeconomic evaluation. Am J Ther. 2013 Jan; 20(1):1.
    View in: PubMed
    Score: 0.576
  2. Somberg JC. Proposed accelerated FDA approvals for special medical use. Am J Ther. 2012 Nov; 19(6):393-4.
    View in: PubMed
    Score: 0.570
  3. Somberg JC. Making America more competitive: a paradigm shift in drug and device development. Am J Ther. 2012 Sep; 19(5):315-6.
    View in: PubMed
    Score: 0.563
  4. Somberg JC. Has the food and drug administration changed the drug approval process? Am J Ther. 2011 May; 18(3):179.
    View in: PubMed
    Score: 0.513
  5. Somberg JC. The Food and Drug Administration's paternalism. Am J Ther. 2010 Nov-Dec; 17(6):533-4.
    View in: PubMed
    Score: 0.496
  6. Somberg J. Supporting therapeutic innovation. Am J Ther. 2009 May-Jun; 16(3):203.
    View in: PubMed
    Score: 0.447
  7. Somberg J. Off-label promotion. Am J Ther. 2006 Sep-Oct; 13(5):387.
    View in: PubMed
    Score: 0.371
  8. Somberg J. Surrogate endpoints and drug approval. Am J Ther. 2006 Sep-Oct; 13(5):388.
    View in: PubMed
    Score: 0.371
  9. Somberg JC. Risk assessment, drug approval, and liability. Am J Ther. 2006 May-Jun; 13(3):181-2.
    View in: PubMed
    Score: 0.363
  10. Somberg JC. Nesiritide: the wrong controversy. Am J Ther. 2005 Sep-Oct; 12(5):377-8.
    View in: PubMed
    Score: 0.347
  11. Somberg JC. The new drug evaluation process: risk benefit ratio. Am J Ther. 2005 May-Jun; 12(3):199-200.
    View in: PubMed
    Score: 0.339
  12. Somberg J. The provisional approval step. Am J Ther. 2005 Jan-Feb; 12(1):1-2.
    View in: PubMed
    Score: 0.331
  13. Somberg J. Drug trial registries. Am J Ther. 2004 Sep-Oct; 11(5):327.
    View in: PubMed
    Score: 0.323
  14. Somberg JC. Biologic problems. Am J Ther. 2002 Nov-Dec; 9(6):471.
    View in: PubMed
    Score: 0.285
  15. Somberg JC, Borer JS. Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory process. Am J Ther. 1999 May; 6(3):175-8.
    View in: PubMed
    Score: 0.223
  16. Somberg JC. Sharing regulatory review costs. J Clin Pharmacol. 1992 Oct; 32(10):867.
    View in: PubMed
    Score: 0.142
  17. Somberg JC, Preston RA, Ranade V, Molnar J. Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010 Jul-Aug; 17(4):365-72.
    View in: PubMed
    Score: 0.121
  18. Somberg J. FDA user fees and innovation. Am J Ther. 2008 Mar-Apr; 15(2):97.
    View in: PubMed
    Score: 0.103
  19. Somberg JC. Class effects of pharmaceuticals and therapeutic interchangeability. Am J Ther. 2001 Jul-Aug; 8(4):221-2.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.